View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Paul Charpentier
  • Paul Charpentier

Worldline - not as weak as expected, but too early to jump in

Worldline reported 2.5% organic growth in Q1 2024, weak in absolute terms but better than anticipated by the market and us. We wait for a clear uptick in momentum and the confirmation of an improved profitability to turn positive on the stock; which is arguably far from expensive at 5.1x EV/NTM EBI

Konrad Zomer
  • Konrad Zomer

Wolters Kluwer : Q1 trading update confirms the ongoing strong operati...

>Ongoing strong operational performance, both margins and FCF up yoy - With Euronext closed today because of Labour day, there is no rush to absorb the content of Wolters Kluwer’s Q1 trading update. It reads well and reflects an ongoing solid operational performance. Organic revenue growth in Q1 was 6% (FY 2023: 6%) with recurring revenue growth 7%, expert solutions up 8% organically (now 59% of the group) and cloud software revenues up 16% (2023: +15%). In Q1, both t...

Louis Boujard ... (+3)
  • Louis Boujard
  • CFA
  • Philippe Ourpatian

Neoen : Un chiffre d’affaires T1 24 parfaitement en ligne et des guida...

>Un chiffre d’affaires T1 24 parfaitement en ligne - Le groupe vient d’annoncer un chiffre d’affaires de 141,4 M€ au T1 24, en ligne avec nos attentes de 144.9 M€, en recul de 8% par rapport au T1 23 et de 6% à taux de change constants. Cette évolution s’explique principalement par un effet de base défavorable lié à la moindre contribution de plusieurs actifs ayant bénéficié de revenus en amont de contrats à long terme et entrés depuis dans le cadre contractuel de lo...

Stefano Toffano
  • Stefano Toffano

DSM-Firmenich : Slowly returning to growth

>No major surprises - DSM-Firmenich posted a relatively weak but in line quarter, with no major surprises on the group level compared to previous communication. The challenging destocking and pricing environment in mainly ANH’s and HNC’s end-markets fed into 2024, resulting in Q1 24 pro-forma revenues and adj. EBITDA of c. € 3,071m (-2% yoy) and € 463m (-11% yoy) respectively, the latter roughly reflecting ccs and AAOB estimates. In line with previous communication, D...

Maissa Keskes ... (+2)
  • Maissa Keskes
  • Stephane Houri

Siltronic AG : Better-than-expected Q1 2024 results, FY 2024 outlook r...

>Strong Q1 24 results - This morning, Siltronic reported its Q1 2024 results which were above expectations. Revenues were € 343.5m, 1% above the consensus at € 340m. They were down 4% q-o-q and down 15% y-o-y. While the wafer area sold and sales prices remained nearly stable compared to the previous quarter, the product mix had a slightly negative impact. The gross margin was 20.4% above with consensus at 14.4%. The operating results was € 36m, giving a margin of 10....

Anthony Dick ... (+2)
  • Anthony Dick
  • Michael Foundoukidis

Stellantis : Back to earth

>An unexpected ‘reset’ and an unfortunate first for Stellantis… - Stellantis on Tuesday reported Q1 sales down 12% at € 41.7bn (-4% vs consensus), hurt by the decline in volumes (-10%) but also FX headwinds (-3%). Also, the OEM clearly confirmed its full-year guidance, albeit providing clarifications that suggest that H1 will be tougher than expected, with a targeted operating margin of between 10.0% and 11.0% (10.5%e) and visibly lower FCF, ahead of a hoped-for impro...

Simmons First National Corp: 1 director

A director at Simmons First National Corp sold/sold after exercising options 15,625 shares at 17.230USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Sten Gustafsson
Martijn Den Drijver
  • Martijn Den Drijver

TKH GROUP NV : Preview Q1 2024: In line with guidance

>Not a great start of the year but in line with guidance - TKH will publish Q1 2024 results on May 6. An analyst call is scheduled for 10h CET. Although we do not have a quarterly model per business unit, we do try to forecast Q1 and Q3 based upon our detailed H1 and H2 forecasts. We forecast sales of €429m (Q1 2023 €473m or €441m restated for the divestment of TKH France) and organic growth of -2.5% (Q1 2023 +8.1%). This is driven by Smart Vision (still modest desto...

Jeremy Garnier
  • Jeremy Garnier

Orège : A deterioration in 2023 results – 2024 should be another trans...

>Sales of € 1.2m, down 64%, underlying operating profit of -€ 7.8m - Orège reported on Tuesday its 2023 earnings that fell short of our forecast. For sales at € 1.2m down 64%, underlying operating profit stood at -€ 7.8m and attributable net profit came to -€ 10.2m. At 31 December 2023, group net debt stood at € 45.2m (debt at € 45.8m of which € 45m is related to advances on the shareholder current account and the cash position of € 0.6m). Since end-2023, a new advan...

Florent Laroche-Joubert ... (+2)
  • Florent Laroche-Joubert
  • Gerardo Ibanez

Metrovacesa : Q1 2024 results: Solid figures on track for their target...

>On track to meet its FY targets - Metrovacesa posted Q1 2024 results broadly in line with our expectations and its FY guidance. From the quarterly results of the company, we highlight the following:Deliveries stood at 364 units (+10% YoY) to generate €140m in revenues during the first quarter upon a higher ASP per unit of €375k due to product mix. We expect company to remain below the 2,000 units to be delivered in 2024. Residential development margin impr...

 PRESS RELEASE

Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a ...

Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein Planegg/Martinsried, May 2, 2024. (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, presented superior T cell receptor engineered T (TCR-T) cell functionality upon combination of optimal affinity 3S (sensitive, specific and safe) TCRs with the PD1-41BB costimulatory switch protein (CSP) at the 7th International Neoantigen Summit held in Amsterdam, Netherlands from A...

 PRESS RELEASE

Notification de participation par BlackRock Inc.

Notification de participation par BlackRock Inc. Notification de participation par BlackRock Inc. Bruxelles, Belgique – 2 mai 2024 - 8:30 CEST Conformément à la législation et réglementation en matière de transparence financière (loi du 2 mai 2007), BlackRock Inc. (50 Hudson Yards, New York, NY, 10001, U.S.A.) a envoyé à Syensqo une notification de transparence indiquant qu’il avait franchi le seuil de 3%. Voici un résumé du mouvement: Date à laquelle le seuil a été franchi Droits de vote après la transaction Instruments financiers équivalents après la transaction Total 25 avril 2...

 PRESS RELEASE

Participatiemelding van BlackRock Inc.

Participatiemelding van BlackRock Inc. Participatiemelding van BlackRock Inc. Brussel, België - 2 Mai 2024 – 8u30 CEST In overeenstemming met de Belgische wetgeving op de openbaring van belangrijke deelnemingen (wet van 2 mei 2007), heeft BlackRock Inc. (50 Hudson Yards, New York, NY, 10001, U.S.A.) een transparantiemelding naar Syensqo gestuurd om aan te geven dat de drempel van 3% is overschreden. Hier is een samenvatting van de beweging: Datum van drempeloverschrijding Stemrechten na de transactie Aan stemrechten gelijkgestelde financiële instrumenten na de transactie Totaal 25...

 PRESS RELEASE

Green Hydrogen Systems announces issuance of warrants to executive man...

Green Hydrogen Systems announces issuance of warrants to executive management and key employees Company announcement 12/2024 Green Hydrogen Systems announces issuance of warrants to executive management and key employees Kolding, Denmark, 1 May 2024 – Green Hydrogen Systems A/S (“Company”) announces the decision to issue warrants for executive management and key employees, who are in a non-terminated position and who were employed on 1 April 2024. The warrant program is established as a long-term incentive scheme reflecting the Company’s objective to attract and retain qualified m...

Can Demir
  • Can Demir

WOOD Flash - Piraeus Financial Holdings: 1Q24 highlights

Piraeus has posted 1Q24 net income figures of EUR 233m and EUR 279m in reported and normalised terms, respectively. This indicates a 3% miss on the reported net income consensus (EUR 239m) and a 5% miss on the normalised net income consensus (EUR 295m). The miss was mainly revenue-driven, where other operating income/loss lines brought in a EUR 67m setback in the quarter, EUR 43m of which was related to the expenses associated with the HFSF stake sale. At first look, 1Q24 seems to have left us w...

Churchill Downs Inc: 1 director

A director at Churchill Downs Inc bought 3,800 shares at 130.220USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

Emmanuel Matot ... (+2)
  • Emmanuel Matot
  • Martin Marandon-Carlhian

Worldline : Début d’année apportant du crédit aux objectifs 2024

>Croissance organique faible au T1 mais au-dessus des attentes - Worldline vient de publier son CA au titre du T1 2024. Il fait ressortir une croissance organique faible à +2.5% mais au-dessus des attentes (ODDO BHF / consensus = +1.2/+0.7%) et en amélioration par rapport au point bas du T4 2023 (+1.3%).Les Services aux Commerçants s’avèrent plus dynamique que prévu (+3.9% dont +6.5% hors arrêt planifié de commerçants – rappel T4 2023 = +3.2%) grâce à de bons rés...

 PRESS RELEASE

Sidetrade and SHS Viveon AG agree public tender offer for SHS Viveon A...

Sidetrade and SHS Viveon AG agree public tender offer for SHS Viveon AG A friendly public tender offer with premium on the SHS Viveon AG sharesTender offer price: €3.00 per SHS Viveon AG share in cashTender offer deadline: June 17, 2024Post-delisting: No open market for SHS Viveon AG shares , the global leader in AI-powered Order-to-Cash applications, today announces its intention to acquire SHS Viveon AG, a German leader in credit risk management software, following an agreement made with its supervisory board. The public tender offer is scheduled for Tuesday May 7, 2024, with plans to...

 PRESS RELEASE

Sidetrade et SHS Viveon AG conviennent d'une offre publique d'achat su...

Sidetrade et SHS Viveon AG conviennent d'une offre publique d'achat sur SHS Viveon AG Une offre publique d'achat amicale avec une prime sur les actions de SHS Viveon AGPrix de l’offre d’achat : 3 euros par action SHS Viveon AGDate limite de l'offre d’achat : 17 juin 2024Après la sortie de cote : Pas d’accès au marché pour les actions SHS Viveon AG , plateforme d’intelligence artificielle (IA) dédiée à la sécurisation et à la génération du cashflow des entreprises, annonce aujourd’hui son intention d'acquérir le leader allemand dans les logiciels de gestion des risques de crédit, SHS Viv...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch